NEA Management Company as of Dec. 31, 2016
Portfolio Holdings for NEA Management Company
NEA Management Company holds 39 positions in its portfolio as reported in the December 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Tesaro | 54.9 | $1.4B | 10M | 134.48 | |
Ardelyx (ARDX) | 8.0 | $200M | 14M | 14.20 | |
Dermira | 4.2 | $106M | 3.5M | 30.33 | |
Epizyme | 3.0 | $76M | 6.3M | 12.10 | |
Senseonics Hldgs (SENS) | 2.8 | $70M | 26M | 2.67 | |
Achaogen | 2.7 | $68M | 5.2M | 13.02 | |
Groupon | 2.6 | $67M | 20M | 3.32 | |
Crispr Therapeutics (CRSP) | 2.6 | $65M | 3.2M | 20.26 | |
Ra Pharmaceuticals | 2.1 | $53M | 3.5M | 15.19 | |
Glycomimetics (GLYC) | 2.1 | $52M | 8.6M | 6.10 | |
Clovis Oncology | 2.0 | $51M | 1.1M | 44.42 | |
Proteostasis Therapeutics In | 1.7 | $44M | 3.6M | 12.26 | |
Adaptimmune Therapeutics (ADAP) | 1.6 | $40M | 9.9M | 4.05 | |
Lexicon Pharmaceuticals (LXRX) | 1.3 | $33M | 2.4M | 13.83 | |
Care | 1.1 | $28M | 3.3M | 8.57 | |
Aerohive Networks | 1.1 | $27M | 4.7M | 5.70 | |
Nevro (NVRO) | 1.0 | $26M | 360k | 72.66 | |
Trevena | 0.9 | $22M | 3.8M | 5.88 | |
Endologix | 0.6 | $14M | 2.5M | 5.72 | |
Tracon Pharmaceuticals | 0.5 | $14M | 2.8M | 4.90 | |
Strongbridge Bioph shs usd | 0.4 | $9.9M | 4.1M | 2.40 | |
Aurinia Pharmaceuticals (AUPH) | 0.3 | $8.5M | 4.1M | 2.10 | |
Rigel Pharmaceuticals | 0.3 | $7.7M | 3.2M | 2.38 | |
Cascadian Therapeutics | 0.3 | $7.7M | 1.8M | 4.31 | |
AVEO Pharmaceuticals | 0.2 | $5.6M | 10M | 0.54 | |
Mirna Therapeutics | 0.2 | $5.4M | 3.0M | 1.80 | |
Sunesis Pharmaceuticals Inc Ne | 0.2 | $4.7M | 1.3M | 3.62 | |
Dasan Zhone Solutions | 0.2 | $4.7M | 4.8M | 0.98 | |
Arca Biopharma | 0.2 | $4.2M | 1.5M | 2.85 | |
Champions Oncology (CSBR) | 0.2 | $4.0M | 1.6M | 2.53 | |
Roka Bioscience | 0.1 | $3.8M | 894k | 4.24 | |
ArQule | 0.1 | $3.2M | 2.5M | 1.26 | |
Akari Therapeutics | 0.1 | $3.2M | 452k | 7.04 | |
Zosano Pharma | 0.1 | $1.6M | 2.1M | 0.78 | |
Paratek Pharmaceuticals | 0.0 | $1.0M | 66k | 15.40 | |
Agile Therapeutics | 0.0 | $761k | 134k | 5.70 | |
Orexigen Therapeutics | 0.0 | $645k | 371k | 1.74 | |
Catalyst Biosciences | 0.0 | $424k | 652k | 0.65 | |
Cerecor | 0.0 | $524k | 595k | 0.88 |